ArticleAACE endocrinology and diabetes
Beyond the Limits: Severe Hyperglycemia in Hyperosmolar Hyperglycemic State (Serum Glucose 2375 mg/dL).
Article in AACE endocrinology and diabetes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Objective: Hyperosmolar hyperglycemic state (HHS) is a life-threatening diabetic emergency characterized by extreme hyperglycemia, dehydration, and absence of significant ketoacidosis. This case is noteworthy due to the patient's extraordinarily high serum glucose level of 2375 mg/dL, one of the highest recorded in literature. This report's objective is to describe a patient with HHS and profound hyperglycemia that challenges the known boundaries of human physiology. Case Presentation: A 28-year-old transgender man (assigned female at birth) receiving testosterone replacement therapy presented to a critical access hospital emergency department with severe nausea, vomiting, and signs of dehydration. He had insulin-dependent type I diabetes mellitus and stage 3 chronic kidney disease. Initial laboratory testing revealed serum glucose of 2375 mg/dL (reference range: 70-140 mg/dL). Laboratory analysis showed no ketoacidosis. He was diagnosed with a hyperosmolar hyperglycemic state. The patient was transferred to our hospital and treated with intravenous fluids and insulin. Laboratory values were closely monitored. Over several days, glucose levels declined to reference ranges. His symptoms resolved, and he was discharged in a stable condition. Discussion: HHS typically occurs in older adults with type 2 diabetes and is associated with infections or organ failure. Serum glucose above 2000 mg/dL is rarely reported. This case stands out due to the significant level of hyperglycemia. Conclusion: This case contributes to limited literature on profound hyperglycemia and emphasizes the importance of early recognition and treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.